MARTINEZ, Calif.--(BUSINESS WIRE)--The first patient has been enrolled in ExThera Medical’s OSCAR I STUDY (ONCObind CTC Removal Study) clinical study at OU Health Stephenson Cancer Center, the ...
Exthera Medical Corp.’s Oncobind procedure hemoperfusion filter reduced circulating tumor cells in blood samples of patients with pancreatic cancer in a study published in Nature’s BJC Reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results